3,4-dihydroxyphenylacetic acid has been researched along with fluorodeoxyglucose f18 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentho, O; Conant, S; Eldadah, BA; Goldstein, DS; Holmes, C; Imrich, R; Moak, J; Sato, T; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P | 1 |
| Baeken, C; De Coninck, M; De Deyn, PP; Demuyser, T; El Arfani, A; Parthoens, J; Servaes, S; Smolders, I; Staelens, S; Van Dam, D; Wyckhuys, T | 1 |
4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Biomarkers; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Septum; Humans; Male; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Sensitivity and Specificity | 2008 |
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve | 2012 |
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; PC12 Cells; Putamen; Rats | 2016 |
Accelerated high-frequency repetitive transcranial magnetic stimulation enhances motor activity in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Dopamine; Fluorodeoxyglucose F18; Glucose; Hydroxyindoleacetic Acid; Male; Motor Activity; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Serotonin; Transcranial Direct Current Stimulation | 2017 |